Literature DB >> 10113226

Willingness to pay for publicly-provided goods. A possible measure of benefit?

C Donaldson1.   

Abstract

The results presented in this paper arise from a U.K.-based study aimed at determining peoples' willingness to pay for two publicly-provided goods, namely continuing-care for elderly people in either hospital or National Health Service (NHS) nursing homes. Seventy-one per cent of respondents provided evaluations which could contribute to the analysis which showed that the group which preferred NHS nursing-home care could potentially compensate the group which preferred hospital care and still remain better off, thus rendering NHS nursing-home care the efficient option to undertake. No variable could be found which discriminated between those who could place a value on both types of care and those who could not. The willingness-to-pay methodology is very experimental in this context and should be investigated thoroughly before its widespread adoption in the evaluation of health care techniques.

Entities:  

Mesh:

Year:  1990        PMID: 10113226     DOI: 10.1016/0167-6296(90)90043-3

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  18 in total

Review 1.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 2.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

3.  The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?

Authors:  M Johannesson
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

4.  Assessing community values in health care: is the 'willingness to pay' method feasible?

Authors:  C Donaldson; S Farrar; T Mapp; A Walker; S Macphee
Journal:  Health Care Anal       Date:  1997-03

5.  Agenda for health: an economic view.

Authors:  C Donaldson
Journal:  BMJ       Date:  1992-03-21

Review 6.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

7.  Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach.

Authors:  P Davey; D Grainger; J MacMillan; N Rajan; M Aristides; M Dobson
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

8.  Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer.

Authors:  Mike Aristides; Jack Chen; Mark Schulz; Eve Williamson; Stephen Clarke; Kaye Grant
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 9.  Outcome measurement in economic evaluations of public health interventions: a role for the capability approach?

Authors:  Paula K Lorgelly; Kenny D Lawson; Elisabeth A L Fenwick; Andrew H Briggs
Journal:  Int J Environ Res Public Health       Date:  2010-05-06       Impact factor: 3.390

10.  The use of willingness to pay to assess public preferences towards the fortification of foodstuffs with folic acid.

Authors:  Simon Dixon; Phil Shackley
Journal:  Health Expect       Date:  2003-06       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.